Industry & Policy News

[European Association for Cancer Research] The European Association for Cancer Research announced that the winner of the 2023 Pezcoller-Marina Larcher Fogazzaro-EACR Women in Cancer Research Award is Dr. Johanna Joyce, whose research expertise is in cancer biology, immunology, and the tumour microenvironment.

[Fred Hutchinson Cancer Center] Dr. Fred Appelbaum, executive vice president of Fred Hutchinson Cancer Research Center, was honored by his peers with a Lifetime Achievement award.

[Nature News] A 53-year-old man in Germany has become at least the third person with HIV to be declared clear of the virus after a procedure that replaced his bone marrow cells with HIV-resistant stem cells from a donor.

[The Brink (Boston University)] The Howard Hughes Medical Institute’s Emerging Pathogens Initiative, which is pulling in 70 scientists from 29 organizations, will include seven Boston University (BU) researchers, who will be part of teams working on the next generation of RNA-based antiviral therapies and investigating microscopic pathogenic parasites called protozoa.

[Ryne Biotechnology] Ryne Biotechnology, Inc. announced that the California Institute for Regenerative Medicine has awarded the company a $4 million Clinical Stage Research Program grant.

Ryne Biotechnology, Inc. announced that the California Institute for Regenerative Medicine has awarded the company a $4 million Clinical Stage Research Program grant.